Both in Pharmaceuticals
Impact BioMedical vs SCYNEXIS
Over the past year IBO returned −38.2% and SCYX returned −22.8%; their daily moves had a correlation of 0.03.
IBO −38.2% SCYX −22.8%Growth of $1, one year, split-adjusted
| Metric | IBO | SCYX |
|---|---|---|
| Price | $4.15 | $3.95 |
| Market cap | $35.5M | $39.3M |
| Today | +3.49% | +3.54% |
| 1 month | −14.3% | −21.6% |
| 6 months | −48.9% | −47.7% |
| Year to date | −34.9% | −22.0% |
| 1 year | −38.5% | −25.3% |
| Revenue growth (YoY) | −57.1% | −82.8% |
| Gross margin | −533.3% | 100.0% |
| Net margin | −23300.0% | 3147.7% |
| P/E (TTM) | 44.9× | — |
| Price / sales | 1,013.0× | 2.0× |
| Net cash | $10.0K | $54.1M |
| Dividend yield | — | — |
| Volatility (60d) | 736.6% | 64.6% |
| Short % of float | 0.2% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).